TrialBritish journal of cancer2015

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer.

S Ohkawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.